Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
Ren-Guo GuanJie MeiWenping LinMin DengShaohua LiRong-Ping GuoPublished in: Hepatology international (2023)
The CRAFITY score is a superior predictor of prognosis and treatment-related AEs in HCC patients treated with locoregional-immunotherapy.
Keyphrases